No Data
Risks Still Elevated At These Prices As Legend Biotech Corporation (NASDAQ:LEGN) Shares Dive 26%
Karyopharm Tapped Lori Macomber Of Legend Biotech As CFO, Effective January 3
Bullish news is here! The central bank and the securities regulatory commission jointly announced that the second swap convenience will be operated starting today, with an expected operation amount of no less than 50 billion yuan.
It is understood that 20 securities and Fund companies participated in the first operation, and the second operation will add more securities and Fund companies as well as five leading Insurance Institutions, with an expected second operation volume of no less than 50 billion yuan.
Breaking Down Legend Biotech: 9 Analysts Share Their Views
Legend Biotech Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)